Mozz, I recall you writing a post on our pain and function data across our phase 2b trial and SAS and NFL program. This post is a favourite of mine. I should bookmark it, but haven’t.
If you can and are inclined, can you repost this one? It would be great to share this content with any new eyes we now may have on us post the 6 month 008 DMOAD signals we have just reported on and attained.
Given we (long term holders) believe pain and function is in the bag, it might be nice to show our progress on this alone (it is our primary outcome in our phase3 trial of course!).
Our juices game is so impressive we forget how well it simply functions on pain and function alone, on grade 3/4 knee OA.
We have a brilliant future
PAR Price at posting:
$1.03 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)